chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: second dose not administered; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 16th December 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follow: The patient was the reporter. The age at vaccination was not applicable for this report. Till the time of reporting patient did not receive 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination. The patient had asked for advice.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: first shot years ago, late second dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on an unknown date about 5 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not applicable for this report. The patient reported that he/ she had received first shot about 5 years ago but never had the second dose, which led to incomplete course of vaccination. The patient enquired if they needed to start over.
Sex: F
Vaccine: VARZOS
Symptoms: Vaccine positive rechallenge
Clinical narrative: Flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Flu shot (patient received yearly flu shot) and Shingrix with an associated reaction of influenza like illness (patient received 1st dose on an unknown date in 2019 and experienced flu-like symptoms, refer linked case US2021192908).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   The reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported but it could be 57 or 58 years old. Two years before the reporting date, the patient had got the Shingix two-shot series and experienced flu-like symptoms for a couple of days. The patient stated that the side effects were expected and had recovered after a day or so. The patient did not specify if side effects occurred after dose 1 or dose 2 or both. The patient did not consent to follow-up and did not want to provide Medical doctor contact information. This case has been linked to US2021AMR193164 and US2021192911, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021192908:same reporter,same patient, same suspect, different dose (1st dose) US-GLAXOSMITHKLINE-US2021AMR193164:same reporter US-GLAXOSMITHKLINE-US2021192911:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Redness where shot was given; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 8th September 2021, the patient received Shingles vaccine. On 10th September 2021, 2 days after receiving Shingles vaccine, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema was not recovered/not resolved.   It was unknown if the reporter considered the injection site erythema to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient received shingles shot two days before the reporting date and experienced redness where the shot was given on the reporting date. The reporter was asking if they should be worried about it.
Sex: M
Vaccine: VARZOS
Symptoms: Influenza like illness
Clinical narrative: flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Flu shot (patient received yearly flu shot) and Shingrix with an associated reaction of influenza like illness (patient received 1st dose on an unknown date and experienced flu-like symptoms, refer linked case US2021192911).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   The reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not reported but it could be 61 or 62 years old. Two years before the reporting date, the patient had got the Shingix two-shot series and experienced flu-like symptoms for a couple of days. The reporter stated that the side effects were expected and had recovered after a day or so. The reporter did not specify if side effects occurred after dose 1 or dose 2 or both. The reporter did not consent to follow-up and stated that she was certain that her husband did not want GlaxoSmithKline to contact his doctor. This case has been linked to US2021AMR193160 and US2021192908, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021192911:same reporter,same patient, same suspect, different dose (1st dose) US-GLAXOSMITHKLINE-US2021192908:same reporter US-GLAXOSMITHKLINE-US2021AMR193160:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Illness
Clinical narrative: Sick/Second shot is really harsh; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (patient had shingles in the past).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported, The patient received the second shot and it was really harsh. The patient was sick for 5 days.  The patient previously had shingles, hence needed the shots, as there were 50 percent chances of getting shingles again without the vaccine.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Intermenstrual bleeding, Limb discomfort, Pain in extremity, Pyrexia
Clinical narrative: Aside from heavy/ sore arm low grade fever and change in appetite, I experienced post menstruated bleeding around the 10th of September until currently. I am also on birth control, this bleeding has been daily and enough to change a panty liner with every time I use the rest room.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Flushing, Injection site pain, Limb discomfort, Mobility decreased
Clinical narrative: Immediately after receiving dose noted discomfort radiating down right arm to hand. Shortly thereafter pain developed between shoulder blades. Face became flushed and itchy.  Event subsided within 1 hour. Although I did not require medical attention I was very uncomfortable during this time. Oddly I felt the vaccine traveling through my body. I also developed pain at the injection site which lasted through the night. I had  difficulty raising my arm. As a precaution I took Benadryl and Tylenol that evening.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Immediately after receiving dose noted discomfort radiating down right arm to hand. Shortly thereafter pain developed between shoulder blades. Face became flushed and itchy.  Event subsided within 1 hour. Although I did not require medical attention I was very uncomfortable during this time. Oddly I felt the vaccine traveling through my body. I also developed pain at the injection site which lasted through the night. I had  difficulty raising my arm. As a precaution I took Benadryl and Tylenol that evening.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pyrexia
Clinical narrative: injection site pain left arm pain feverish
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Decreased appetite, Feeling abnormal, Headache
Clinical narrative: Headaches; Chills; Feverish; Weak; Light was bothering her; Sound was bothering her; No appetite; Started feeling bad next day; This case was reported by a other health professional via sales rep and described the occurrence of headache in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th July 2021, the patient received the 1st dose of Shingrix. In July 2021, less than a day after receiving Shingrix, the patient experienced headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad. The patient was treated with hydrocodone. On an unknown date, the outcome of the headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad were recovering/resolving.   It was unknown if the reporter considered the headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad to be related to Shingrix.  Additional details were provided as follows: The patient was vaccinated with Shingrix in the pharmacy and experienced headaches, chills, felt feverish, weak, light and sound was bothering her and had no appetite. The patient started feeling bad the next day, less than 24 hours after vaccination. The patient took a hydrocodone to make herself feel better. The symptoms lasted through next day after vaccination, but patient felt better 2 days later. The reporter consented to follow-up.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Hyperacusis, Photophobia, Pyrexia
Clinical narrative: Headaches; Chills; Feverish; Weak; Light was bothering her; Sound was bothering her; No appetite; Started feeling bad next day; This case was reported by a other health professional via sales rep and described the occurrence of headache in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th July 2021, the patient received the 1st dose of Shingrix. In July 2021, less than a day after receiving Shingrix, the patient experienced headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad. The patient was treated with hydrocodone. On an unknown date, the outcome of the headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad were recovering/resolving.   It was unknown if the reporter considered the headache, chills, fever, weakness, photophobia, sound sensitivity increased, appetite absent and feeling bad to be related to Shingrix.  Additional details were provided as follows: The patient was vaccinated with Shingrix in the pharmacy and experienced headaches, chills, felt feverish, weak, light and sound was bothering her and had no appetite. The patient started feeling bad the next day, less than 24 hours after vaccination. The patient took a hydrocodone to make herself feel better. The symptoms lasted through next day after vaccination, but patient felt better 2 days later. The reporter consented to follow-up.
Sex: U
Vaccine: COVID19, FLUX, VARZOS
Symptoms: Pain in extremity
Clinical narrative: Arm pain; This case was reported by a consumer interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis and COVID-19 VACCINE (COVID 19 VACCINE) for prophylaxis.   On 8th September 2021, the patient received Shingles vaccine, Influenza vaccine Quadrivalent 2020-2021 season and the 3rd dose of COVID 19 VACCINE. On 8th September 2021, less than a day after receiving Shingles vaccine and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine and Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were reported as follows: This case was reported by the patient for herself/himself. The age at vaccination was not reported. On the date of reporting, the patient got the Covid shot, flu shot and shingles shot and mentioned that arm hurts. The contacts details were not reported hence follow up not possible. It was unknown if the reporter considered the pain in arm to be related to Covid shot.
Sex: U
Vaccine: VARZOS
Symptoms: Fatigue, Headache, Lymphadenopathy, Pain
Clinical narrative: Swollen gland under my arm  that received the shot; Achy; Tired; Slight headache; This case was reported by a consumer via (Shingrix GSK Chatbot) interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th September 2021, the patient received the 1st dose of Shingrix. On 8th September 2021, 1 days after receiving Shingrix, the patient experienced pain, tiredness and headache. On 9th September 2021, the patient experienced axillary lymph nodes enlarged. On an unknown date, the outcome of the pain, tiredness and headache were recovering/resolving and the outcome of the axillary lymph nodes enlarged was not recovered/not resolved.   It was unknown if the reporter considered the pain, tiredness, headache and axillary lymph nodes enlarged to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient received vaccine two days before the reporting date and felt achy, tired and had a slight headache one day after vaccination. On the morning of the reporting date, the patient woke up feeling better but had a swollen gland under their arm that received the shot.  The patient was asking if this was a normal reaction.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via other manufacturer and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included disability.   On an unknown date, the patient received Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix.  Additional details were provided as follows: The patient received the Shingrix, about a year ago from the date of reporting. The age at vaccination not reported. She mentioned that, it did not work it was a total placebo. After receiving Shingrix, the patient had the shingles for about a year and she described it as the worst shingles that she had ever had. The patient had gotten the shingles vaccinations since they became available and they had always worked on her.  She spent on the vaccine and did not cover it, she paid for it and it did not work at all.  She would keep receiving a replacement, another inoculation at no charge since the one she got did not work.  The patient was given PMI phone number, reporter also said she had a vocal disability. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Fatigue, Pyrexia
Clinical narrative: tiredness; fever; stomach; This case was reported by a consumer via (Shingrix interactive digital media and described the occurrence of tiredness in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th September 2021, the patient received Shingrix. On 9th September 2021, 1 days after receiving Shingrix, the patient experienced tiredness, fever and stomach pain. On an unknown date, the outcome of the tiredness, fever and stomach pain were unknown.   It was unknown if the reporter considered the tiredness, fever and stomach pain to be related to Shingrix.  Additional details provided were as follows: The reporter was the daughter of the patient. Age at vaccination was not reported. The patient received the the Shingrix shot and at the time of reporting experienced the common side effects of tiredness, stomach, and fever. The reporter asked how long will these side effects will last. Follow-up would not be possible as no contact details available.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination, Social problem
Clinical narrative: supposed to have #2 around Apr 2020 but did not due to covid; This case was reported by a consumer via call center representative and described the occurrence of social problem in a 38-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on an unknown date in December 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The patient-self reported this case. The age at vaccination was not applicable for this report. The patient was about to receive the second dose around April 2020, but did not due to covid. The patient enquired if he/she could take the second dose and if it would be effective.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included chickenpox (as a child).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles, but it was very mild and resolved quickly. The patient was glad to get the Shingles vaccine. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Chills, Feeling abnormal, Pain in extremity
Clinical narrative: hurt; chills; felt awful; This case was reported by a consumer via media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain, chills and feels awful. On an unknown date, the outcome of the pain was recovered/resolved and the outcome of the chills and feels awful were unknown.   It was unknown if the reporter considered the pain, chills and feels awful to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient received a dose of Shingles vaccine and stated hurt like hell and spent a day or two to recoup, the patient also had chills and felt awful. The patient declined the 2nd and stated that hope he/she was the only one. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. The patient stated that, Shingles vaccine could give shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (twice).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles again. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: F
Vaccine: COVID19, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis.   On an unknown date, the patient received Shingles vaccine and COVID-19 VACCINE. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported for the reporter's mother. The age at vaccination was not reported. The patient received Shingles vaccine, several years ago from the date of reporting. Recently the patient received Covid vaccine and a week later, the patient got shingles. It was unknown if the reporter considered the shingles to be related to COVID-19 VACCINE. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Post herpetic neuralgia, Vaccination failure
Clinical narrative: suspected vaccination failure; contracted Shingles; still hurts of the nerve line it traveled.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and post herpetic neuralgia. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the post herpetic neuralgia was not recovered/not resolved.   The reporter considered the vaccination failure, shingles and post herpetic neuralgia to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient's friend. The age at vaccination was not reported. The reporter got shingles twice, not as bad last time but it was close to one eye. The reporter did not trust Shingles vaccine after the patient contracted shingles from Shingles vaccine. After many years till the time of reporting, it still hurt of the nerve line it travelled. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Condition aggravated, Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; get them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported for the reporter's mother. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Immediate post-injection reaction
Clinical narrative: shingles; This case was reported by a consumer via media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided are as follows: The reporter know the patient. The age at vaccination was not reported. The patient got shingles right after getting the shingles shot. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Malaise, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; ill; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and unwell. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and unwell were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and unwell to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient became ill with shingles. The patient's recovery time was lengthy of many many months. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient still got shingles. The patient stated that, it did not prevent shingles, it kept the break outs becoming too aggressive. Till the time of reporting, the patient still had to get the antiviral upon the first days. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; had it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles twice. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: COVID19, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: vaccine for shingles, After the covid vaccine I got Shingles/suspected vaccination failure; I got Shingles.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE for prophylaxis.   The patient's past medical history included chickenpox (had in 3rd grade).   On an unknown date, the patient received Shingles vaccine and COVID-19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got Shingles and after the covid vaccine, the patient got the shingles. On an unknown date, unknown after receiving Covid 19 vaccine, the patient experienced shingles.  It was unknown if the reporter considered the shingles to be related to Covid 19 vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got vaccinated and still have gotten shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the vaccinated with Shingles and still had got shingles 4 times. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: COVID19, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got the vaccine and broke out/suspected vaccination failure; broke out; This case was reported by a consumer via (social media) interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 VACCINE (COVID 19 VACCINE) for prophylaxis.   On an unknown date, the patient received Shingles vaccine and COVID 19 VACCINE. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the Shingles vaccine and broke out with shingles from the covid vaccine. On an unknown date, unknown after receiving Covid 19 vaccine, the patient experienced shingles.  It was unknown if the reporter considered the shingles to be related to Covid 19 vaccine. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Illness, Pain
Clinical narrative: It hurt like hell; was sick for 12 hours; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain and sickness. On an unknown date, the outcome of the pain was unknown and the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the pain and sickness to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received a Shingles shot and was hurt like hell was sick for 12 hours, but nothing like what would happen if he/she were to get Shingles. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; shingles/vaccination isn't a walk in the park; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: The patient self reported the case. The age at vaccination was not reported. The patient had shingles and stated, it was no joke, the vaccination was not a walk in the park either. The patient added that, one have to receive 2 doses of shingles and be sure to ask doctor or pharmacist to explain the side effects. This case was considered as suspected vaccination failure, since the details regarding the time to onset for event and laboratory confirmation for herpes zoster were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Suspected vaccination failure; shingles; Very painful.; This case was reported by a consumer via  interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were reported as follows: The patient self reported the case. The age at vaccination was not reported. The patient got the vaccine and 2 years later hot shingles. The patient mentioned that, it did not always work but very painful. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for herpes zoster were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: had vaccine got shingles/ suspected vaccination failure; got shingles; This case was reported by a consumer via (facebook) interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had Shingles vaccine but got shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation for shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Extra dose administered, Herpes zoster, Vaccination failure
Clinical narrative: Have had 3 shingles shots; Diagnosed September 5. Have had 3 shots; Diagnosed September 5; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 3rd dose of Shingles vaccine. On 5th September 2021, unknown after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the patient experienced extra dose administered. On an unknown date, the outcome of the vaccination failure, shingles and extra dose administered were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient had 3 shingles shots which led to extra dose administered. The patient was diagnosed with shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Chills, Illness, Loss of consciousness, Pyrexia
Clinical narrative: practically unconscious sick in bed; got so sick from that first Shingrix vax, horrible; fever for 18 hours; chills for 18 hours; This case was reported by a consumer via interactive digital media and described the occurrence of unconscious in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced unconscious (serious criteria GSK medically significant), sickness, fever and chills. On an unknown date, the outcome of the unconscious, sickness, fever and chills were recovered/resolved.   It was unknown if the reporter considered the unconscious, fever and chills to be related to Shingrix. The reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient reported that, he/she got so sick from that first Shingrix vaccine.  The patient was practically unconscious sick in bed with fever and chills for 18 hours and stated was horrible. The follow-up would not possible as no contact details were available.